NR

Nebula Research & Development LLC

Long-term holder

Total reported value

Reporting period: 2026-03-31 · Number of holdings: 1

Nebula Research & Development LLC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
0
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
0
Diversification
2
Sizing Uniformity

Recent moves

  • Unchanged 000000000

     $0.0

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1Ikena Oncology INCStock-Other

Holding changes this quarter

Position changes disclosed by Nebula Research & Development LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1Ikena Oncology INCUnchanged

FAQ

What is Nebula Research & Development LLC and what type of investor is it?
Nebula Research & Development LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Nebula Research & Development LLC's largest equity positions?
Based on the latest 13F filing, Nebula Research & Development LLC's top holdings by market value are: 1. Ikena Oncology INC — $0.0
What changes did Nebula Research & Development LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for Nebula Research & Development LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Nebula Research & Development LLC focus on?
Sector breakdown data is not yet available for Nebula Research & Development LLC. Check back after the next 13F processing cycle.